Optiver Holding
OLMA icon

Optiver Holding’s Olema Pharmaceuticals OLMA Stock Holding History

Optiver Holding’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.54K Sell
203
-128
-39% -$1.72K ﹤0.01% 2240
2026
Q1 		$4.93K Sell
331
-8
-2% -$178 ﹤0.01% 1427
2025
Q4 		$8.47K Buy
339
+103
+44% +$1.83K ﹤0.01% 1185
2025
Q3 		$2.31K Buy
+236
New +$1.42K ﹤0.01% 2332

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Optiver Holding's OLMA Position: Q2 2026 in Review

Optiver Holding reduced its Olema Pharmaceuticals (OLMA) stake by 39% in Q2 2026, selling an estimated $1.72K and leaving 203 shares worth $2.54K. The position accounts for ﹤0.01% of the portfolio, ranked #2240.

Optiver Holding first reported a position in OLMA in Q3 2025 and has held it in 4 quarters since. The position peaked at $8.47K in Q4 2025. 185 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

  • Optiver Holding held 203 shares of Olema Pharmaceuticals worth $2.54K as of Q2 2026.
  • Optiver Holding sold 128 Olema Pharmaceuticals shares in Q2 2026, an estimated $1.72K.
  • Olema Pharmaceuticals made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #2240 holding.
  • Optiver Holding first reported a position in Olema Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • Optiver Holding's Olema Pharmaceuticals position peaked at $8.47K in Q4 2025.
  • 185 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.